Press "Enter" to skip to content

New patent for Puma Biotech drug NERLYNX

0
Copyright © DrugPatentWatch. Originally published at New patent for Puma Biotech drug NERLYNX

Annual Drug Patent Expirations for NERLYNX
Annual Drug Patent Expirations for NERLYNX

Nerlynx is a drug marketed by Puma Biotech and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.

This drug has one hundred and seventeen patent family members in twenty-nine countries.

The generic ingredient in NERLYNX is neratinib maleate. One supplier is listed for this compound. Additional details are available on the neratinib maleate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Puma Biotech drug NERLYNX
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions